中文(简体)
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Pistachios Blood Sugar Control, Heart and Gut Health

只有注册用户可以翻译文章
登陆注册
链接已保存到剪贴板
状态招聘中
赞助商
Penn State University

关键词

抽象

A two-period randomized crossover study will be conducted to evaluate the effect of nighttime pistachio consumption (i.e., after dinner and before sleep) on fasting blood sugar levels, longer-term blood sugar control, and risk factors for heart disease. This study will also investigate how pistachios affects gut health.

描述

A two-period randomized crossover trial will be conducted. Participants will be randomized to receive each treatment for 12 weeks followed by a minimum 4-week wash-out period. During the pistachio treatment, participants will consume two ounces per day (57 g) of pistachios as an evening snack. During the control phase subjects will be given advice to consume 1-2 exchanges of carbohydrate as an evening snack, which is consistent with usual care. Markers of glycemic control, cardiovascular risk factors and gut health will be assessed at the beginning and the end of each treatment period.

日期

最后验证: 08/31/2019
首次提交: 08/11/2019
提交的预估入学人数: 08/12/2019
首次发布: 08/13/2019
上次提交的更新: 09/16/2019
最近更新发布: 09/17/2019
实际学习开始日期: 09/08/2019
预计主要完成日期: 05/29/2021
预计完成日期: 05/29/2021

状况或疾病

Type 2 Diabetes
Cardiovascular Diseases

干预/治疗

Drug: Evening Pistachio Consumption

Other: Usual care

相 2

手臂组

干预/治疗
Active Comparator: Evening Pistachio Consumption
Participants will consume two ounces per day (57 g) of pistachios as an evening snack (i.e., after dinner and before sleep).
Drug: Evening Pistachio Consumption
Unsalted pistachios
Active Comparator: Usual care
Advice to consume a snack that contains 1-2 exchanges (15-30 g of carbohydrate) as an evening snack - this is consistent with the current standard of care for people with impaired fasting glucose.
Other: Usual care
Advice and resources will be provided

资格标准

有资格学习的年龄 30 Years 至 30 Years
有资格学习的性别All
接受健康志愿者
标准

Inclusion Criteria:

- BMI ≥25 and ≤45 kg/m2

- Fasting plasma glucose 100 - 125 mg/dL

- non-Smoking

Exclusion Criteria:

- Diagnosed diabetes or fasting glucose >126 mg/dl

- Systolic blood pressure >160mmHg or diastolic blood pressure >100mmHg)

- Prescribed anti-hypertensive, lipid lowering or glucose lowering drugs

- Established cardiovascular disease, stroke, diabetes, liver, kidney or autoimmune disease or inflammatory conditions

- Use of supplements (psyllium, fish oil, soy lecithin, phytoestrogens) and botanicals and not willing to cease for the duration of the study

- Women who are pregnant, lactating, planning to become pregnant or have given birth in the past year

- Weight loss of >=10% of body weight within the 6 months prior to enrolling in the study

- Smoking or use of any tobacco products

- Allergy/intolerance/sensitive to pistachios

- Consumption of >14 alcoholic drinks/week

- Shift-workers and those who cannot consume a snack in the evening

结果

主要结果指标

1. Fasting plasma glucose concentration [12 weeks]

fasting blood glucose assessed by blood draw and expressed in mg/dL

次要成果指标

1. HbA1c [12 weeks]

HbA1c assessed by blood draw and expressed in micro IU/mL

2. Serum insulin concentration [12 weeks]

fasting serum insulin levels assessed by blood draw and expressed in micro IU/mL

3. Peripheral systolic and diastolic blood pressure [12 weeks]

Blood pressure measured assessed using a SphymoCor Ecel (Atcor Medical).

4. Central systolic and diastolic blood pressure [12 weeks]

Blood pressure measured assessed using a SphymoCor Ecel (Atcor Medical).

5. Carotid-femoral pulse wave velocity [12 weeks]

A measure of arterial stiffness assessed using a SphymoCor Ecel (Atcor Medical). A higher percentage value is indicative of greater arterial stiffness.

6. Augmentation Index (%) [12 weeks]

A measure of arterial stiffness assessed using a SphymoCor Ecel (Atcor Medical). A higher percentage value is indicative of greater arterial stiffness.

7. LDL cholesterol concentration [12 weeks]

Assessed using fasting blood draw

8. HDL cholesterol concentration [12 weeks]

Assessed using fasting blood draw

9. Total cholesterol concentration [12 weeks]

Assessed using fasting blood draw

10. Triglyceride concentration [12 weeks]

Assessed using fasting blood draw

11. HOMA-IR [12 weeks]

Assessed using fasting blood draw and standardized HOMA-IR calculation. Fasting plasma glucose multiplied by fasting plasma insulin divided by 405.

12. waist circumference [12 weeks]

Measured 10 cm above the navel

13. body weight [12 weeks]

Assessed using calibrated scale in Clinical Research Center

14. Diet quality: Healthy Eating Index 2015 [12 weeks]

Assessed using the Healthy Eating Index 2015

15. Change in the composition of the gut microbiome [12 weeks]

microbiome composition assessed using fecal collection kit

加入我们的脸书专页

科学支持的最完整的草药数据库

  • 支持55种语言
  • 科学支持的草药疗法
  • 通过图像识别草药
  • 交互式GPS地图-在位置标记草药(即将推出)
  • 阅读与您的搜索相关的科学出版物
  • 通过药效搜索药草
  • 组织您的兴趣并及时了解新闻研究,临床试验和专利

输入症状或疾病,并阅读可能有用的草药,输入草药并查看所使用的疾病和症状。
*所有信息均基于已发表的科学研究

Google Play badgeApp Store badge